PTEN and neoplasm: The EpDT3-modified Ad5-PTEN gene delivery system can enhance gene expression and cellular uptake in HepG2 cells, inhibit cell proliferation and migration of HepG2, and show superior anti-tumor activity against aggressive HepG2 xenografts in nude mice [58, 59].